当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:163.30亿  总市值:164.49亿
流通股本:4.11亿   总股本:4.14亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金678,413,231.824,907,751,773.513,584,309,809.632,448,099,733.1
收到的税费返还702,086.1729,369,879.2223,904,404.9819,977,850.43
收到其他与经营活动有关的现金97,996,066.65194,614,881.91176,040,886.65109,229,062.21
经营活动现金流入的平衡项目0000
经营活动现金流入小计777,111,384.645,131,736,534.643,784,255,101.262,577,306,645.74
购买商品、接受劳务支付的现金311,556,439.031,946,420,301.681,515,900,082.581,072,559,388.05
支付给职工以及为职工支付的现金344,153,214.011,328,746,612.591,050,773,258.03733,619,691.93
支付的各项税费43,234,686.47174,173,341.2118,745,406.02101,262,941.78
支付其他与经营活动有关的现金154,104,406.711,273,628,427.8916,710,977.22661,752,290.81
经营活动现金流出的平衡项目0000
经营活动现金流出小计853,048,746.224,722,968,683.273,602,129,723.852,569,194,312.57
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-75,937,361.58408,767,851.37182,125,377.418,112,333.17
二、投资活动产生的现金流量:
收回投资收到的现金1,070,048,204.513,332,077,841.452,559,015,173.051,829,015,173.05
取得投资收益收到的现金8,337,985.15240,245,823.66230,408,727.84196,915,554.6
处置固定资产、无形资产和其他长期资产收回的现金净额4,087,044.232,716,45047,179.751,955.08
收到的其他与投资活动有关的现金-11,736,557.697,113,191.726,892,536.45
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,082,473,233.893,586,776,672.82,796,584,272.362,032,825,219.18
购建固定资产、无形资产和其他长期资产支付的现金109,149,926.711,236,385,209.3945,821,053.49522,483,929.6
投资支付的现金1,557,082,297.054,095,787,296.211,917,850,772.711,458,457,217.11
支付其他与投资活动有关的现金-5,344,949.777,297,834.927,077,179.65
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,666,232,223.765,337,517,455.282,870,969,661.121,988,018,326.36
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-583,758,989.87-1,750,740,782.48-74,385,388.7644,806,892.82
三、筹资活动产生的现金流量:
吸收投资收到的现金--5,000,000-
取得借款收到的现金32,399,758.83251,678,162.82239,234,247.12150,000,000
收到其他与筹资活动有关的现金-82,850,551.84115,324,066115,324,066
筹资活动现金流入平衡项目0000
筹资活动现金流入小计32,399,758.83334,528,714.66359,558,313.12265,324,066
偿还债务支付的现金6,000,00012,000,0006,000,000-
分配股利、利润或偿付利息支付的现金1,776,787.3416,734,734.9415,419,983.01414,258,316.34
支付其他与筹资活动有关的现金21,958,174.42172,676,186.77152,130,995.97126,837,007.32
筹资活动现金流出平衡项目0000
筹资活动现金流出小计29,734,961.72601,410,921.67573,550,978.98541,095,323.66
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额2,664,797.11-266,882,207.01-213,992,665.86-275,771,257.66
四、汇率变动对现金及现金等价物的影响12,789,626.1932,822,168.0370,166,392.96100,418,411.53
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-644,241,928.15-1,576,032,970.09-36,086,284.25-122,433,620.14
加:期初现金及现金等价物余额3,555,141,076.985,131,174,047.075,131,174,047.075,129,191,988.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,910,899,148.833,555,141,076.985,095,087,762.825,006,758,368.72
补充资料:
净利润-93,681,843.43-51,919,525.71
资产减值准备-96,273,989.03-14,656,502.42
固定资产和投资性房地产折旧-312,206,699.84-155,920,186.33
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-312,206,699.84-155,920,186.33
无形资产摊销-57,607,586.97-35,375,541.28
长期待摊费用摊销-36,145,952.84-16,428,888.41
处置固定资产、无形资产和其他长期资产的损失--2,763,827.65--1,860,385.38
固定资产报废损失-5,711,218.48-2,835,488.58
公允价值变动损失-34,357,341.9-35,915,976.59
财务费用-66,676,273.68-6,292,675.81
投资损失--1,284,630.6--29,753,967.21
递延所得税-24,938,090.76--23,488,488.88
其中:递延所得税资产减少-15,316,543.17--8,972,897.94
递延所得税负债增加-9,621,547.59--14,515,590.94
存货的减少-103,781,748.13-117,000,987.96
经营性应收项目的减少-736,488,070.75-362,166,907.59
经营性应付项目的增加--1,344,884,203.19--772,132,818.43
其他-122,809,861.85--
债务转为资本-46,494,875--
不涉及现金收支的投资和筹资活动金额其他项目-41,710,934--
现金的期末余额-3,555,141,076.98-5,006,758,368.72
减:现金的期初余额-5,131,174,047.07-5,129,191,988.86
公告日期2024-04-272024-04-132023-10-282023-08-12
审计意见(境内)标准无保留意见
TOP↑